Subcutaneous delivery of daratumumab in Japanese patients with RRMM: A phase 1 study

Shinsuke Iida

Presentation information

Oral Session

Oral Session 3-10A MM: Clinical trials

Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Yasushi Takamatsu (Division of Medical Oncology, Hematology and Infections Diseases, Fukuoka University, Japan)

[OS3-10A-1] Subcutaneous delivery of daratumumab in Japanese patients with RRMM: A phase 1 study

Shinsuke Iida¹, Morio Matsumoto², Hiroshi Kosugi³, Hidehisa Noguchi⁴, Akiko Suzuki⁴, Hiroshi Yamazaki⁴, Hirohiko Shibayama⁵ (1.Hematol.&Oncol. Nagoya City University, Nagoya, Japan, 2.Hematol. National Hospital Org. Sibukawa Medical Center, Shibukawa, Japan, 3.Ogaki Municipal Hospital, Ogaki, Japan, 4.Janssen Pharmaceutical K.K. , Tokyo, Japan, 5.Osaka Univ. Grad. Schl. Med., Osaka, Japan)

Abstract password authentication.
Password is written on a program and abstract book.